![Cumberland Pharmaceuticals Announces Breakthrough Results from Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease](https://marketsgonewild.com/wp-content/uploads/2025/02/unnamed-file-45-600x360.jpg)
Cumberland Pharmaceuticals Announces Breakthrough Results from Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
NASHVILLE, Tenn. , Feb. 4, 2025 /PRNewswire/ — Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) FIGHT DMD Trial Results Exciting News in Pharmaceutical Development Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company known for its focus on developing new products for rare diseases, has recently made waves in the medical world with the announcement of positive top-line results…